Tuesday, July 14, 2015

Radius Health - Barchart Chart of the day

Radius Heath (RDUS) is the Barchart Chart of the Day.  The biopharmaceutical company has a Trend Spotter buy signal, a Weighted Alpha of 324.60+ and gained 524.08% in the last year.

The Chart of the Day belongs to Radius Health (RDUS).  I found the biopharmaceutical stock by sorting today's All Time High list for the stocks with the highest Weighted Alpha then used the Flipchart feature to review the charts.  Since the Trend Spotter signaled a buy on 5/12 the stock gained 83.47%.

Radius Health Inc. is a science-driven biopharmaceutical company. It is focused on developing novel differentiated therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases. The Company's lead product candidate, abaloparatide (BA058), is in development, in both injection (Abaloparatide-SC) and transdermal (Abaloparatide-TD) methods of administration, for the prevention of fractures in post-menopausal women at risk of fracture from osteoporosis. Radius Health Inc. is based in Cambridge, Massachusetts.


The status of Barchart's Opinion trading systems are listed below.  Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates.  The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.

Barchart technical indicators:

  • 96% Barchart technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 14 new highs and up 62.41% in the last month
  • Relative Strength index 80.27%
  • Barchart computes a technical support level at 71.01%
  • Recently traded at 77.76 with a 50 day moving average of 53.46
Fundamental factors:
  • Market Cap $2.95 billion
  • Revenue expected to increase 47.50% this year, an additional 34.00% next year and continue to compound at an annual rate of 4..10% for the next 5 years
  • Wall Street analysts issued 5 strong buy and 1 hold recommendation on the stock
The 50 day moving average vs prices has been an effective technical trading strategy on this stock.

No comments:

Post a Comment